Aquestive therapeutics appoints mark lepore, md, as chief medical officer for allergy

Warren, n.j., jan. 28, 2021 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst), a pharmaceutical company focused on developing and commercializing differentiated products that address patients' unmet needs and solve therapeutic problems, today announced the appointment of mark lepore, md, as the chief medical officer for allergy.
AQST Ratings Summary
AQST Quant Ranking